HOME >> BIOLOGY >> NEWS
Arsenic Shown To Induce Cancer Remission

New York, November 5, 1998 -- Arsenic, a notorious poison, may be on the verge of overcoming its bad reputation. Two years ago, Chinese researchers reported that low doses of arsenic trioxide induced remission in patients with acute promyelocytic leukemia (APL), prompting physicians in the West to undertake their own pilot study.

Researchers at Memorial Sloan-Kettering Cancer Center have now become the first investigators in the Western world to show that arsenic effectively induces remission in patients who have relapsed with APL, a potentially fatal type of cancer that affects the blood and bone marrow. The findings are reported in the November 5 issue of the New England Journal of Medicine.

"We now know that arsenic can safely bring patients with APL into remission, which may ultimately give them a second chance at life," said Dr. Raymond P. Warrell, Jr., the senior author of the study and a leukemia specialist at Memorial Sloan-Kettering Cancer Center.

In the pilot study, 12 patients who had relapsed from conventional therapy were treated with low doses of arsenic trioxide. Eleven of the 12 patients achieved remission anywhere from 12 to 39 days after treatment started, experiencing only mild side effects.

The single patient who failed to reach remission died from a complication related to the disease five days after arsenic treatment began and could not be evaluated in the study.

Once remission was achieved, each patient received a brief treatment break, which was followed with repeated courses of arsenic trioxide therapy every three to six weeks thereafter. After two cycles of therapy, the investigators conducted additional tests to determine whether any molecular evidence of leukemia remained. Three patients tested positive for molecular evidence of the disease and later relapsed with APL, while eight patients tested negative for molecular evidence of APL and remained in remissions that lasted as long as 10 months. To date, seve
'"/>

Contact: Kelli Stauning
stauningk@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
4-Nov-1998


Page: 1 2

Related biology news :

1. Arsenic in New England wells more widespread than thought
2. Arsenic in drinking water may be linked to cancer Dartmouth study finds
3. Arsenic in Bangladesh drinking wells may be linked to crop irrigation, MIT study finds
4. Arsenic and old telomeres
5. Arsenic and old telomerase: Hopkins researchers unravel effects of arsenic on human cells
6. Marine Life In South Pacific Region Found To Be Impervious To Oceans Highest Arsenic Levels
7. New Hampshire Study Shows Well Water Has Higher Arsenic Levels Than Municipal Water
8. New Drug Shown Effective Against Vancomycin-Resistant Bacteria
9. High Temperature Immediately Following A Stroke Leads To Worse Outcome; Quick Cooling Shown To Have Benefit
10. Binding Proteins Shown To Play Key Role In Early Brain Development
11. Irregular Heartbeat Shown To Increase Risk Of Death As Well As Disability; Particularly Harmful To Women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... ... cell culture models into their drug discovery research workflows with biology ranging from ... in vivo relevancy of in vitro studies, they create several challenges that need ...
(Date:12/22/2018)... BOSTON (PRWEB) , ... December 21, 2018 , ... ... office sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, ... Opportunities Arising from China.” , The discussion was moderated by patent attorney ...
(Date:12/18/2018)... ... December 18, 2018 , ... The nation’s leader ... client marketing. The technology has been effective at reducing patient acquisition costs by ... working with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem ...
Breaking Biology News(10 mins):
(Date:12/19/2018)... ... 2018 , ... RURO, Inc., a leading provider of information ... The new release enhances the latest version of Limfinity®, RURO’s software framework, and ... , Validation protocols, and their execution, are critical for software systems scrutinized by ...
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... ... business process optimization firm for the life sciences industry, unveiled a completely redesigned ... while creating a more user-friendly browsing experience for their valued clients and business ...
(Date:12/14/2018)... EDMONTON, Alberta (PRWEB) , ... December 14, 2018 ... ... the Eye Machine Canada Inc., have been given the green light to immediately ... Age-Related Macular Degeneration (AMD). , The medical devices bureau of Health Canada has ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... life science software solutions, announces the Limfinity® ML (Machine Learning) addition for its ... machine learning models within Limfinity® solutions. In the module, trained models make predictions ...
Breaking Biology Technology:
Cached News: